Head of Intellectual Property
Mrs. Shelby Walker is an accomplished intellectual property and legal executive in the life sciences. Prior to joining our company, Shelby served as General Counsel at Gingko Bioworks, a synthetic biology company. Before that, she served as Vice President, Associate General Counsel and Chief IP Counsel at Dyax Corporation. Prior to Dyax, Shelby served as IP Counsel at Novo Nordisk and as Senior Patent Attorney at ZymoGenetics. Shelby holds a J.D. and LL.M. in Intellectual Property Law from the University of New Hampshire School of Law, an M.S. in Biotechnology and an M.S. in Regulatory Science, both from Johns Hopkins University and a B.S. in Biotechnology from Worcester Polytechnic Institute.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.